NEUROLOGICAL SYMPTOMS AND SERUM VITAMIN B12 LEVELS CORRELATE IN COVID-19 PATIENTS
DOI:
https://doi.org/10.52340/jecm.2024.01.03Keywords:
Covid 19, Vitamin 12, NeurologyAbstract
At the beginning of the COVID-19 pandemic, olfactory and gustatory changes were common, and they were associated with vitamin B12 deficiency. From early 2022 we observed post-COVID neurological symptoms that significantly worsened the patient's quality of life, and because of this, the patients were referred to primary care. The objective of our research was to evaluate the vitamin B12 deficiency correlation to post-COVID neurological symptoms. 312 patients with laboratory-confirmed COVID-19 were included in the research. All the patients suffered from self-rated symptoms such as memory problems, impaired concentration, mood changes, tingling sensation, and/or weakness of muscles. All patients either denied having these symptoms before the COVID-19 infection or claimed that having these symptoms did not affect their quality of life. Using standard enzyme-linked immunosorbent assay (ELISA) serum vitamin B12 levels in the patients were measured. The study showed that 85% of patients had low levels of vitamin B12. Based on the laboratory results, patients have been prescribed a daily dose of peroral vitamin B12 therapy for 2 months. Patients with a severe deficiency were initially given the injectable form for the first ten days, followed by a switch to the tablet form. Upon completing the treatment, all patients reported a significant reduction or complete disappearance of their symptoms. Based on our study we recommend the monitoring of vitamin B12 levels in patients presenting with neurological symptoms developed after COVID-19 infection. The study also showed that oral supplementation alone may not be sufficient to achieve the desirable level of vitamin B12 in all patients.
Downloads
References
Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020;579(7798):265–269
Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020;277(08):2251–2261. Doi: 10.1007/s00405-020-05965-1
Meng X, Deng Y, Dai Z, Meng Z. COVID-19 and anosmia: A review based on up-to-date knowledge. Am J Otolaryngol 2020;41(05): 102581
Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope 2020;130 (07):1787. Doi: 10.1002/lary.28692
Gane SB, Kelly C, Hopkins C. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology 2020;58(03):299–301. Doi: 10.4193/Rhin20.114
World Health Organization. Vitamin B12. In: Vitamin and Mineral Requirements in Human Nutrition: Report of a Joint FAO/WHO Expert Consultation. 2nd ed. Bangkok, Thailand: World Health Organization; 1998:279–288
Tamura J, Kubota K, Murakami H, et al. Immunomodulation by vitamin B12: augmentation of CD8+ T lymphocytes and natural killer (NK) cell activity in vitamin B12-deficient patients by methyl-B12 treatment. Clin Exp Immunol. 1999; 116:28–32.
Yoshii K, Hosomi K, Sawane K, et al. Metabolism of dietary and microbial vitamin B family in the regulation of host immunity. Front Nutr. 2019; 6:48.
Wolffenbuttel BHR, Wouters HJCM, Heiner-Fokkema MR, et al. The many faces of cobalamin (vitamin B12) deficiency. Mayo Clin Proc Innov Qual Outcomes. 2019; 3:200–214
Kulkarni R, Rajput U, Dawre R, et al. Severe malnutrition and anemia are associated with severe COVID in infants. J Trop Pediatr. 2021;67:fmaa084
Degnan PH, Taga ME, Goodman AL. Vitamin B12 as a modulator of gut microbial ecology. Cell Metab. 2014;20:769–778
Kandeel M, Al-Nazawi M.. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Life Sci. 2020; 251:117627.
Stabler SP, Allen RH. Vitamin B12 deficiency as a worldwide problem. Annu Rev Nutr. 2004;24:299–326
Allen LH. How common is vitamin B-12 deficiency? Am J Clin Nutr. 2009;89:693S–696S.
Allen LH, Miller JW, De Groot L, et al. Biomarkers of Nutrition for Development (BOND): vitamin B-12 review. J Nutr. 2018;148:1995S–2027S
Rizzo G, Laganà AS, Rapisarda AMC, et al. Vitamin B12 among vegetarians: status, assessment, and supplementation. Nutrients. 2016;8:767.
O'Leary F, Samman S. Vitamin B12 in health and disease. Nutrients. 2010;2:299–316.
Bahouth S, Chuang K, Olson L, et al. COVID-19 related muscle denervation atrophy. Skeletal Radiol. 2021;50:1717–1721.
Abu-Rumeileh S, Abdelhak A, Foschi M, et al. Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2021;268:1133–1170.
Raahimi MM, Kane A, Moore CE, et al. Late onset of Guillain-Barré syndrome following SARS-CoV-2 infection: part of “long COVID-19 syndrome.” BMJ Case Rep. 2021;14:E240178.
Wang H, Li L, Quin LL, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2018;2018:CD004655
Letizia Mauro G, Martorana U, Cataldo P, et al. Vitamin B12 in low back pain: a randomised, double-blind, placebo-controlled study. Eur Rev Med Pharmacol Sci. 2000;4:53–58
Stein J, Geisel J, Obeid R. Association between neuropathy and B-vitamins: a systematic review and meta-analysis. Eur J Neurol. 2021;28:2054–2064.
Didangelos T, Karlafti E, Kotzakioulafi E, et al. Vitamin B12 supplementation in diabetic neuropathy: a 1-year, randomized, double-blind, placebo-controlled trial. Nutrients. 2021;13:395
Sun Y, Lai M-S, Lu C-J. Effectiveness of vitamin B12 on diabetic neuropathy: systematic review of clinical controlled trials. Acta Neurol Taiwan. 2005;14:48–54.
Butler CC, Vidal-Alaball J, Cannings-John R, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: a systematic review of randomized controlled trials. Fam Pract. 2006;23:279–285.
Wang JY, Wu YH, Liu SJ, et al. Vitamin B12 for herpetic neuralgia: a meta-analysis of randomised controlled trials. Complement Ther Med. 2018;41:277–282
Idal-Alaball J, Butler C, Cannings-John R, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2005;CD004655.
Downloads
Published
How to Cite
Issue
Section
